Citation: E. Allan et al., CONSTRUCTION AND CHARACTERIZATION OF A HELICOBACTER-PYLORI CLPB MUTANT AND ROLE OF THE GENE IN THE STRESS-RESPONSE, Journal of bacteriology, 180(2), 1998, pp. 426-429
Authors:
LI CG
KUMAR S
LEDGER PW
PONTING JM
CARETTE M
ALLAN E
Citation: Cg. Li et al., GLUCOSAMINYLMURAMYL DIPEPTIDE (GMDP) MODULATES ENDOTHELIAL-CELL ACTIVITIES IN-VITRO BUT HAS NO EFFECT ON ANGIOGENESIS IN-VIVO, Inflammation research, 46(9), 1997, pp. 348-353
Authors:
BERMAN I
VIEGNER B
MERSON A
ALLAN E
PAPPAS D
GREEN AI
Citation: I. Berman et al., DIFFERENTIAL RELATIONSHIPS BETWEEN POSITIVE AND NEGATIVE SYMPTOMS ANDNEUROPSYCHOLOGICAL DEFICITS IN SCHIZOPHRENIA, Schizophrenia research, 25(1), 1997, pp. 1-10
Authors:
ALLAN E
SISON C
ALPERT M
CONNOLLY B
CRICHTON J
Citation: E. Allan et al., ATYPICAL NEUROLEPTICS AND THE RELATIONSHIP BETWEEN NEGATIVE SYMPTOMS OF SCHIZOPHRENIA AND EXTRAPYRAMIDAL SIDE-EFFECTS, Psychopharmacology bulletin, 33(3), 1997, pp. 489-489
Authors:
KRAMER MS
LAST B
GETSON A
REINES SA
SILVA JA
WIRSHING W
CONLEY R
ALLAN E
CHENG HY
CHAVEZENG C
Citation: Ms. Kramer et al., THE EFFECTS OF A SELECTIVE D-4 DOPAMINE-RECEPTOR ANTAGONIST (L-745,870) IN ACUTELY PSYCHOTIC INPATIENTS WITH SCHIZOPHRENIA, Archives of general psychiatry, 54(6), 1997, pp. 567-572
Authors:
ZIMBROFF DL
KANE JM
TAMMINGA CA
DANIEL DG
MACK RJ
WOZNIAK PJ
SEBREE TB
WALLIN BA
KASHKIN KB
ADAN F
AINSLIE G
ALLAN E
ATRI P
BAKER R
BEITMAN B
BROWN G
CANIVE J
CARMAN J
DOTT S
EDWARDS J
FENTON W
FREIDLI J
FUNDERBURG L
ERESHEFSKY L
GLADSON M
HAMILTON J
HAQUE S
HARTFORD J
HORNE R
HOUCK C
JAMPALA C
LABELLE A
LARSON G
LESEM M
LISKOW B
MAKELA E
MOORE N
MORPHY M
POSEVER T
RISCH S
ROTROSEN J
SHEEHAN D
SILVERSTONE P
SWANN A
TAPP A
THOMAS M
VOLAVKA J
VORA S
Citation: Dl. Zimbroff et al., CONTROLLED, DOSE-RESPONSE STUDY OF SERTINDOLE AND HALOPERIDOL IN THE TREATMENT OF SCHIZOPHRENIA, The American journal of psychiatry, 154(6), 1997, pp. 782-791
Authors:
BERMAN I
MERSON A
RACHOVPAVLOV J
ALLAN E
DAVIDSON M
LOSONCZY MF
Citation: I. Berman et al., RISPERIDONE IN ELDERLY SCHIZOPHRENIC-PATIENTS - AN OPEN-LABEL TRIAL, The American journal of geriatric psychiatry, 4(2), 1996, pp. 173-179
Citation: J. Marjoram et al., SCREENING FOR COLORECTAL-CANCER - A GENERAL-PRACTICE-BASED STUDY, British journal of general practice, 46(406), 1996, pp. 283-286
Citation: D. Steffensmeier et E. Allan, GENDER AND CRIME - TOWARD A GENDERED THEORY OF FEMALE OFFENDING, Annual review of sociology, 22, 1996, pp. 459-487
Authors:
ALPERT M
ALLAN E
SISON C
POUGET E
PARKER L
WIDMER D
Citation: M. Alpert et al., A COMPARISON OF CLOZAPINE OR OLANZAPINE VERSUS HALOPERIDOL IN TREATMENT-RESISTANT SCHIZOPHRENIA-PATIENTS - ACOUSTIC MEASURES OF CHANGES IN FLUENCY, Psychopharmacology bulletin, 32(3), 1996, pp. 407-407
Authors:
KRAMER M
ZIMBROFF D
LAST B
GETSON A
HAFEZ H
ALPERT M
ROTROSEN J
MCEVOY J
KANE J
MERIDETH C
SILVA A
ERESHEFSKY L
MARDER S
CONLEY R
ALLAN E
KRONIG M
AMES D
WIRSHING W
CHAVEZENG C
CHENG HY
REINES S
Citation: M. Kramer et al., THE EFFECTS OF A SELECTIVE D-4 ANTAGONIST (L-745,870) IN ACUTELY PSYCHOTIC SCHIZOPHRENIC-PATIENTS, Psychopharmacology bulletin, 32(3), 1996, pp. 467-467
Authors:
BERMAN I
MERSON A
SISON C
ALLAN E
SCHAEFER C
LOBERBOYM M
LOSONCZY MF
Citation: I. Berman et al., REGIONAL CEREBRAL BLOOD-FLOW CHANGES ASSOCIATED WITH RISPERIDONE TREATMENT IN ELDERLY SCHIZOPHRENIA-PATIENTS - A PILOT-STUDY, Psychopharmacology bulletin, 32(1), 1996, pp. 95-100
Citation: E. Allan et al., ANTI-BACTEROIDES LIPOPOLYSACCHARIDE IGG LEVELS IN HEALTHY-ADULTS AND SEPSIS PATIENTS, FEMS immunology and medical microbiology, 11(1), 1995, pp. 5-12
Citation: E. Allan et Ir. Poxton, THE INFLUENCE OF GROWTH-MEDIUM ON SERUM SENSITIVITY OF BACTEROIDES SPECIES, Journal of Medical Microbiology, 41(1), 1994, pp. 45-50
Authors:
MCEWAN SR
DAVIES HTO
ALLAN E
MACLEAN D
FORBES CD
Citation: Sr. Mcewan et al., MEASUREMENT AND MANAGEMENT OF CARDIOVASCULAR RISK-FACTORS - IS SCREENING WORTHWHILE, Scottish Medical Journal, 38(6), 1993, pp. 173-177